Shareholders Foundation, Inc.

NASDAQ:EYEG Shareholder Notice: Investigation over Possible Securities Laws Violations by EyeGate Pharmaceuticals, Inc.

An investigation for investors in EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) shares over potential securities laws violations by EyeGate Pharmaceuticals, Inc. was announced.

 

San Diego, CA -- (SBWIRE) -- 11/09/2021 -- An investigation was announced concerning possible violations of securities laws by EyeGate Pharmaceuticals, Inc. in connection with certain financial statements.

Investors who purchased shares of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) concerning whether a series of statements by EyeGate Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Waltham, MA based EyeGate Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system in the United States. EyeGate Pharmaceuticals, Inc. reported that its annual Total Revenue declined from $2.68 million in 2019 to $0.012 million in 2020, and that its Net Loss increased from $7.09 million in 2019 to $8.17 million in 2020.

Shares of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) declined from over $12 per share in late 2019 to as low as $1.44 per share in August 2021.

On November 8, 2021, NASDAQ: EYEG shares closed at $1.82 per share.

Those who purchased shares of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.